Background Malaria is a major public health problem in endemic countries including Sudan,
where about 75% of populations are at risk. Due to widespread of chloroquine-resistant …

Background Artemisinin combination therapy (ACT) is recommended as first-line treatment
for uncomplicated Plasmodium falciparum malaria, whereas chloroquine is still commonly …

Background Artemisinin-based combination therapy (ACT) was deployed in 2005 as an
alternative to chloroquine and is considered the most efficacious treatment currently …

Introduction Artemisinin-based combination therapies (ACTs) are the first-line antimalarial
drugs used to treat uncomplicated Plasmodium falciparum alaria in many endemic countries …

Background The efficacy of artemisinin-based combination therapy has already been
demonstrated in a number of studies all over the world, and some of them can be regarded …

The artemisinin-based combination therapy (ACT) is adopted by several countries as first
line for malaria treatment in the last decade. Concomitantly, the World Health Organization …

Background Artemisinin-based combination therapy (ACT) is the treatment of choice for
uncomplicated Plasmodium falciparum malaria in most areas of the world, where malaria is …

Background The World Health Organization recommends uncomplicated P. falciparum
malaria is treated using Artemisinin‐based Combination Therapy (ACT). This review aims to …

Background Sub-Saharan Africa has the highest burden of malaria in the world. Artemisinin-
based combination therapies (ACTs) have been the cornerstone in the efforts to reduce the …

Background Artemisinin-based combination therapy (ACT) has been adopted by the World
Health Organization as a first-line treatment for uncomplicated Plasmodium falciparum …